The DOI matches its Crossref record; 44 of the 49 references it cites were found in a registry or an index.
Proportion of Cancer Cases Attributable to Excess Body Weight by US State, 2011-2015
Open accessAbstract
Importance: Excess body weight (EBW) is an established cause of cancer. Despite variations in the prevalence of EBW among US states, there is little information on the EBW-related cancer burden by state; this information would be useful for setting priorities for cancer-control initiatives. Objective: To calculate the population attributable fraction (PAF) of incident cancer cases attributable to EBW among adults 30 years or older in 2011 to 2015 in all 50 states and the District of Columbia. Design, Setting, and Participants: State-level, self-reported body mass index (BMI [calculated as weight in kilograms divided by height in meters squared]) data from the Behavioral Risk Factor Surveillance System were adjusted by sex, age, race/ethnicity, and education using objectively measured BMI values from the National Health and Nutrition Examination Survey. Age- and sex-specific cancer incidence data by state were obtained from the US Cancer Statistics database. All analyses were performed between February 15, 2018, and July 17, 2018. Main Outcomes and Measures: Sex-, age-, and state-specific adjusted prevalence estimates for 4 high BMI categories and corresponding relative risks from large-scale pooled analyses or meta-analyses were used to compute the PAFs for each US state for esophageal adenocarcinoma, multiple myeloma, and cancers of the gastric cardia, colorectum, liver, gallbladder, pancreas, female breast, corpus uteri, ovary, kidney and renal pelvis, and thyroid. Results: Each year, an estimated 37 670 cancer cases in men (4.7% of all cancer cases excluding nonmelanoma skin cancers) and 74 690 cancer cases in women (9.6%) 30 years or older in the United States were attributable to EBW from 2011 to 2015. In both men and women, there was at least a 1.5-fold difference in the proportions of cancers attributable to EBW between states with the highest and lowest PAFs. Among men, the PAF ranged from 3.9% (95% CI, 3.6%-4.3%) in Montana to 6.0% (95% CI, 5.6%-6.4%) in Texas. The PAF for women was approximately twice as high as for men, ranging from 7.1% (95% CI, 6.7%-7.6%) in Hawaii to 11.4% (95% CI, 10.7%-12.2%) in the District of Columbia. The largest PAFs were found mostly in southern and midwestern states, as well as Alaska and the District of Columbia. Conclusions and Relevance: The proportion of cancers attributable to EBW varies among states, but EBW accounts for at least 1 in 17 of all incident cancers in each state. Broad implementation of known community- and individual-level interventions is needed to reduce access to and marketing of unhealthy foods (eg, through a tax on sugary drinks) and to promote and increase access to healthy foods and physical activity, as well as preventive care.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Obesity, characterized by excessive body fat, constitutes a major risk factor for the development of type 2 diabetes (T2D), dyslipidemia, cardiometabolic disease1, cancer2, and overall mortality3.”
From Transforming obesity: The advancement of multi-receptor drugs (2024) · cites this paper as [2]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R. L., Miller, K. D., & Jemal, A. (2018) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21442 · Cited by 16,632
Self-citationRenehan, A. G., Tyson, M., Egger, M., Heller, R. F., & Zwahlen, M. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60269-x · Cited by 5,219
Body Fatness and Cancer — Viewpoint of the IARC Working Group
Lauby-Secretan, B., Scoccianti, C., Loomis, D., Grosse, Y., Bianchini, F., & Straif, K. (2016) · New England Journal of Medicine · doi:10.1056/nejmsr1606602 · Cited by 3,596
Kushi, L. H., Byers, T., Doyle, C., Bandera, E. V., McCullough, M., Gansler, T., Andrews, K. S., Thun, M. J., & The American Cancer Society 2006 Nutrition and Physical Activity Guidelines Advisory Committee (2006) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.56.5.254 · Cited by 1,901
Hales, C. M., Fryar, C. D., Carroll, M. D., Freedman, D. S., & Ogden, C. L. (2018) · JAMA · doi:10.1001/jama.2018.3060 · Cited by 1,761
Islami, F., Goding Sauer, A., Miller, K. D., Siegel, R. L., Fedewa, S. A., Jacobs, E. J., McCullough, M. L., Patel, A. V., Ma, J., Soerjomataram, I., et al. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21440 · Cited by 1,610
Self-citationMokdad (2018) · doi:10.1001/jama.2018.0158 · Cited by 1,517
American Cancer Society guidelines on nutrition and physical activity for cancer prevention
Kushi, L. H., Doyle, C., McCullough, M. L., Rock, C. L., Demark‐Wahnefried, W., Bandera, E. V., Gapstur, S. M., Patel, A. V., Andrews, K. S., & Gansler, T. S. (2012) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.20140 · Cited by 1,399
Self-citationColchero, M. A., Popkin, B. M., Rivera, J. Á., & Ng, S. W. (2016) · BMJ · doi:10.1136/bmj.h6704 · Cited by 881
Screening for Obesity in Children and Adolescents
US Preventive Services Task Force, Grossman, D. C., Bibbins-Domingo, K. B., Curry, S. J., Barry, M. J., Davidson, K. W., Doubeni, C. A., Epling, J. W., Kemper, A. R., Krist, A. H., et al. (2017) · JAMA · doi:10.1001/jama.2017.6803 · Cited by 837
Research works printed but not linked: 1
- American Cancer Society Cancer Action Network. How do you measure up? A progress report on state legislative activity to reduce cancer incidence and mortality, 15th Edition. https://www.fightcancer.org/sites/default/files/National%20Documents/HDYMU-2017.pdf. Accessed March 14, 2018.
Cited by
Sorted by citations
Obesity Shapes Metabolism in the Tumor Microenvironment to Suppress Anti-Tumor Immunity
Ringel, A. E., Drijvers, J. M., Baker, G. J., Catozzi, A., García-Cañaveras, J. C., Gassaway, B. M., Miller, B. C., Juneja, V. R., Nguyen, T. H., Joshi, S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.11.009 · Cited by 780
Obesity and Cancer: A Current Overview of Epidemiology, Pathogenesis, Outcomes, and Management
Pati, S., Irfan, W., Jameel, A., Ahmed, S., & Shahid, R. K. (2023) · Cancers · doi:10.3390/cancers15020485 · Cited by 677
Review: Diabetes, Obesity, and Cancer—Pathophysiology and Clinical Implications
Lega, I. C., & Lipscombe, L. L. (2019) · Endocrine Reviews · doi:10.1210/endrev/bnz014 · Cited by 381
Healthy Lifestyle and Cancer Risk: Modifiable Risk Factors to Prevent Cancer
Marino, P., Mininni, M., Deiana, G., Marino, G., Divella, R., Bochicchio, I., Giuliano, A., Lapadula, S., Lettini, A. R., & Sanseverino, F. (2024) · Nutrients · doi:10.3390/nu16060800 · Cited by 292
Islami, F., Marlow, E. C., Thomson, B., McCullough, M. L., Rumgay, H., Gapstur, S. M., Patel, A. V., Soerjomataram, I., & Jemal, A. (2024) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21858 · Cited by 228
Self-citationObesity induces PD-1 on macrophages to suppress anti-tumour immunity
Bader, J. E., Wolf, M. M., Lupica-Tondo, G. L., Madden, M. Z., Reinfeld, B. I., Arner, E. N., Hathaway, E. S., Steiner, K. K., Needle, G. A., Hatem, Z., et al. (2024) · Nature · doi:10.1038/s41586-024-07529-3 · Cited by 191
Li, M., Gong, W., Wang, S., & Li, Z. (2022) · BMJ Open · doi:10.1136/bmjopen-2022-065425 · Cited by 152
Transforming obesity: The advancement of multi-receptor drugs
Kusminski, C. M., Perez-Tilve, D., Müller, T. D., DiMarchi, R. D., Tschöp, M. H., & Scherer, P. E. (2024) · Cell · doi:10.1016/j.cell.2024.06.003 · Cited by 126
SGLT2 inhibition slows tumor growth in mice by reversing hyperinsulinemia
Nasiri, A. R., Rodrigues, M. R. D. S., Li, Z., Leitner, B. P., & Perry, R. J. (2019) · Cancer & Metabolism · doi:10.1186/s40170-019-0203-1 · Cited by 116
Madak‐Erdogan, Z., Band, S., Zhao, Y. C., Smith, B. P., Kulkoyluoglu‐Cotul, E., Zuo, Q., Casiano, A. S., Wrobel, K., Rossi, G., Smith, R. L., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-2849 · Cited by 114
The effects of age and systemic metabolism on anti-tumor T cell responses
Drijvers, J. M., Sharpe, A. H., & Haigis, M. C. (2020) · eLife · doi:10.7554/elife.62420 · Cited by 69
Body Mass Index and Risk of Second Cancer Among Women With Breast Cancer
Feigelson, H. S., Bodelón, C., Powers, J. D., Curtis, R. E., Buist, D. S. M., Veiga, L. H. S., Bowles, E. J. A., de González, A. B., & Gierach, G. L. (2021) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djab053 · Cited by 71
Total Energy Intake: Implications for Epidemiologic Analyses
McCullough, L. E., & Byrd, D. A. (2022) · American Journal of Epidemiology · doi:10.1093/aje/kwac071 · Cited by 62
Sex and Gender Differences in Obesity: Biological, Sociocultural, and Clinical Perspectives
Kim, H., Kim, S., & Sung, M. (2025) · The World Journal of Men s Health · doi:10.5534/wjmh.250126 · Cited by 79
Cancer and Obesity: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022
Lazarus, E., & Bays, H. E. (2022) · Obesity Pillars · doi:10.1016/j.obpill.2022.100026 · Cited by 55
The effect of GLP-1R agonists on the medical triad of obesity, diabetes, and cancer
Ibrahim, S. S., Ibrahim, R. S., Arabi, B., Brockmueller, A., Shakibaei, M., & Büsselberg, D. (2024) · Cancer and Metastasis Reviews · doi:10.1007/s10555-024-10192-9 · Cited by 56
Obesity, obesities and gastrointestinal cancers
Zou, Y., & Pitchumoni, C. S. (2023) · Disease-a-Month · doi:10.1016/j.disamonth.2023.101592 · Cited by 47
Population Attributable Risks of Subtypes of Esophageal and Gastric Cancers in the United States
Wang, S., Katki, H. A., Graubard, B. I., Kahle, L., Chaturvedi, A. K., Matthews, C. E., Freedman, N. D., & Abnet, C. C. (2021) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001355 · Cited by 44
Association of Body Mass Index With the Safety Profile of Nivolumab With or Without Ipilimumab
McQuade, J. L., Hammers, H. J., Furberg, H. F., Engert, A., André, T., Blumenschein, G. R., Tannir, N. M., Baron, A. D., Larkin, J., El-Khoueiry, A. B., et al. (2022) · JAMA Oncology · doi:10.1001/jamaoncol.2022.5409 · Cited by 40
Shen, S., Brown, K. A., Green, A. K., & Iyengar, N. M. (2026) · JAMA · doi:10.1001/jama.2026.1114 · Cited by 44
Lifestyle considerations in multiple myeloma
Shapiro, Y. N., Peppercorn, J. M., Yee, A. J., Branagan, A. R., Raje, N. S., & O’Donnell, E. (2021) · Blood Cancer Journal · doi:10.1038/s41408-021-00560-x · Cited by 37
Excess body fatness and cancer risk: a summary of the epidemiologic evidence
Patel, A. V., Patel, K. S., & Teras, L. R. (2023) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2023.01.025 · Cited by 31
Yang, T.-H., Chan, C., Yang, P.-J., Huang, Y., & Lee, M. (2023) · Viruses · doi:10.3390/v15020559 · Cited by 31
Association between diabetes, obesity, aging, and cancer: review of recent literature
Qiang, J. K., Lipscombe, L. L., & Lega, I. C. (2020) · Translational Cancer Research · doi:10.21037/tcr.2020.03.14 · Cited by 28
Oleic Acid Dissolves cGAS–DNA Phase Separation to Inhibit Immune Surveillance
Wang, L., Liu, Q., Wang, N., Li, S., Bian, W., Sun, Z., Wang, L., Wang, L., Liu, C., Song, C., et al. (2023) · Advanced Science · doi:10.1002/advs.202206820 · Cited by 24
Germline Risk Contribution to Genomic Instability in Multiple Myeloma
Janz, S., Zhan, F., Sun, F., Cheng, Y., Pisano, M. D., Yang, Y., Goldschmidt, H., & Hari, P. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00424 · Cited by 23
Obesity Paradox in Cancer: A Complex Interplay Between Risk and Therapeutic Outcomes
Chen, T., Zhai, W., Song, J., Liu, W., Wu, Z., Yang, F., & Wang, L. (2025) · MedComm · doi:10.1002/mco2.70494 · Cited by 22
Zhang, G., Cao, F., Shi, L., Ma, T., & Zhang, L. (2019) · Digestive and Liver Disease · doi:10.1016/j.dld.2019.10.012 · Cited by 19
Lin, Y., Zheng, L., Fang, K., Zheng, Y., Wu, J., & Zheng, M. (2023) · International Journal of Epidemiology · doi:10.1093/ije/dyad100 · Cited by 19
Management of cancer-associated thromboembolism in vulnerable population
Laporte, S., Benhamou, Y., Bertoletti, L., Frère, C., Hanon, O., Couturaud, F., Moustafa, F., Mismetti, P., Sanchez, O., & Mahé, I. (2023) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2023.11.009 · Cited by 19
RADAKRISHNAN, A., AGRAWAL, S., SINGH, N., Barbieri, A., Shaw, L. J., Gulati, M., & Lala, A. (2025) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2025.01.008 · Cited by 19
Zhang, C., Zhou, L., Li, S., Zhao, J., Meng, X., Ma, L., Wang, Y., Li, C., Zheng, L., & Ming, L. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.215918 · Cited by 18
Safiri, S., Karamzad, N., Kaufman, J. S., Nejadghaderi, S. A., Bragazzi, N. L., Sullman, M. J. M., Almasi‐Hashiani, A., Mansournia, M. A., Collins, P. G. S., Kolahi, A., et al. (2022) · Obesity · doi:10.1002/oby.23355 · Cited by 18
Self-citationPoint of Care Measurement of Body Mass Index and Thyroid Nodule Malignancy Risk Assessment
Ahmadi, S., Παππά, Θ., Kang, A. S., Coleman, A., Landa, I., Marqusee, E., Kim, M., Angell, T. E., & Alexander, E. K. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.824226 · Cited by 16
A validated estimate of visceral adipose tissue volume in relation to cancer risk
Lu, Y., Zhao, Y. C., Liu, K., Bever, A. M., Zhou, Z., Wang, K., Fang, Z., Polychronidis, G., Liu, Y., Tao, L., et al. (2024) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djae193 · Cited by 16
Pruthi, D. K., Miller, G., Ankerst, D. P., Neumair, M., Umberto Capitanio, A., Correa, A. F., Lane, B. R., Roussel, E., McGregor, T. B., Derweesh, I., et al. (2023) · The Journal of Urology · doi:10.1097/ju.0000000000003650 · Cited by 15
Islami, F., Wiese, D., Marlow, E. C., Kratzer, T. B., Massey, J., Sung, H., & Jemal, A. (2023) · Cancer · doi:10.1002/cncr.34808 · Cited by 14
Self-citationThyroid cancer incidence trend and association with obesity, physical activity in the United States
Chen, B., Xie, Z., & Duan, X. (2022) · BMC Public Health · doi:10.1186/s12889-022-13727-3 · Cited by 14
Mortality trends of colorectal cancer among overweight patients at the global and national levels
Cao, F., Li, F., Shi, L., Zhang, L., Ma, T., & Zhang, G. (2019) · International Journal of Colorectal Disease · doi:10.1007/s00384-019-03371-6 · Cited by 13
Blyth, R. R. R., Birts, C. N., & Beers, S. A. (2023) · Breast Cancer Research · doi:10.1186/s13058-023-01700-w · Cited by 13
Artificial intelligence in anti-obesity drug discovery: unlocking next-generation therapeutics
Gangwal, A., & Lavecchia, A. (2025) · Drug Discovery Today · doi:10.1016/j.drudis.2025.104333 · Cited by 13
Weight gain in midlife women: Understanding drivers and underlying mechanisms
Grammatikopoulou, M. G., Nigdelis, M. P., & Goulis, D. G. (2022) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2022.100406 · Cited by 18
Sex Differences in the Impact of Obesity on Immunity
Vijayakumar, S., Pantha, S., Magar, S. B., & Dhakal, S. (2026) · Immunological Reviews · doi:10.1111/imr.70101 · Cited by 10
Paul, D., & Nedelcu, A. M. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1040034 · Cited by 11
All-cause mortality attributable to sitting time and physical inactivity in chilean adults
Stingl-Zúñiga, I., Farías‐Valenzuela, C., Hernández, P. A. F., Marques, A., Rezende, L. F. M., Castillo-Paredes, A., Cristi‐Montero, C., Sadarangani, K. P., & Ferrari, G. (2023) · BMC Public Health · doi:10.1186/s12889-023-16467-0 · Cited by 12
Deng, Z., Hajihosseini, M., Moore, J. X., Khan, S., Graff, R. E., Bondy, M. L., Chung, B. I., & Langston, M. E. (2023) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-23-0668 · Cited by 10
An emergency medicine review: Multiple myeloma and its complications
Long, B., McCurdy, A. B. R., Koyfman, A., & Rosenberg, H. (2024) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2024.11.073 · Cited by 11
Radakrishnan, A., Agrawal, S., Singh, N., Barbieri, A., Shaw, L. J., Gulati, M., & Lala, A. (2025) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2025.100928 · Cited by 12
Yin, Y., Xu, X. M., Shen, L., Zhao, W., Diao, H., & Li, C. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.644645 · Cited by 10
Song, R., Riseberg, E., Petimar, J., Wang, M., Mucci, L. A., Wu, K., Zhang, X., Willett, W. C., Giovannucci, E. L., & Smith‐Warner, S. A. (2023) · British Journal of Cancer · doi:10.1038/s41416-023-02314-x · Cited by 9
Kang, L., Chen, X., Qi, P., Ma, Z., Han, D., Zhang, X., & Shang, P. (2024) · Translational Cancer Research · doi:10.21037/tcr-24-744 · Cited by 8
KASE, N. G., Friedman, E. G., & Brodman, M. L. (2020) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2020.06.008 · Cited by 8
Diseases Prediction from Officially Anonymized Medical and Healthcare Big Data
Kikuchi, H., Ito, S., Ikegami, K., & Shindo, S. (2022) · IEEE International Conference on Big Data (BigData) · doi:10.1109/bigdata55660.2022.10075547 · Cited by 7
Lifetime body weight patterns, weight loss, and renal cell carcinoma subtypes
Deng, Z., Zhang, C. A., Moore, J. X., Khan, S., Graff, R. E., Batai, K., Bondy, M. L., Chung, B. I., & Langston, M. E. (2025) · Cancer · doi:10.1002/cncr.35763 · Cited by 7
Zheng, S., Yin, J., Yue, H., & Li, L. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1191206 · Cited by 9
Kao, Y.-K., Lin, H., Chen, C., Su, Y., & Chen, J. (2021) · Obesity Surgery · doi:10.1007/s11695-021-05511-w · Cited by 7
Body Mass Index, Physical Activity, and Subsequent Neoplasm Risk Among Childhood Cancer Survivors
Joffe, L., Mirzaei, S., Bhatia, S., Darji, H., Ness, K. K., Onerup, A., Ladas, E. J., Im, C., Lupo, P. J., Oeffinger, K. C., et al. (2025) · JAMA Oncology · doi:10.1001/jamaoncol.2025.1340 · Cited by 7
The Complex Connection between Obesity and Cancer: Signaling Pathways and Therapeutic Implications
El‐Tanani, M., Rabbani, S. A., Aljabali, A. A. A., Matalka, I. I., El‐Tanani, Y., Rizzo, M., & Tambuwala, M. M. (2024) · Nutrition and Cancer · doi:10.1080/01635581.2024.2361964 · Cited by 7
Kassab, P., Ferraz, Á. A. B., MITIDIERI, A. C. H., BERTI, L. V., Santo, M. A., Szego, T., Zanon, C. D. C., Castro, O. A. P., de Freitas, W. R., Ilias, E. J., et al. (2024) · ABCD Arquivos Brasileiros de Cirurgia Digestiva (São Paulo) · doi:10.1590/0102-6720202400044e1838 · Cited by 6
Harrison, R. F., Zhao, H., Sun, C. C., Fu, S., Armbruster, S. D., Westin, S. N., Rauh‐Hain, J. A., Lu, K. H., Giordano, S. H., & Meyer, L. A. (2019) · International Journal of Gynecological Cancer · doi:10.1136/ijgc-2019-000999 · Cited by 6
Exploring the impact of body mass index on tumor biology and cancer development
Ahrenfeldt, J., Carstensen, S., Eriksen, I. M. H., & Birkbak, N. J. (2024) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-024-05890-4 · Cited by 7
Sultan, I. Y., Amarin, J. Z., Mansour, R. A., Sultan, H., & Al-Hussaini, M. A. (2021) · Epidemiologia · doi:10.3390/epidemiologia2030029 · Cited by 6
Insulin receptor loss impairs mammary tumorigenesis in mice
Podmore, L., Poloz, Y., Iorio, C., Mouaaz, S., Nixon, K., Smirnov, P., McDonnell, B., Lam, S. H. L., Zhang, B., Tharmapalan, P., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113251 · Cited by 7
Distinct brain and neurocognitive transformations after bariatric surgery: a pilot study
Roy, B., Thedim, M., Liew, C., Kumar, R., & Vacas, S. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1454284 · Cited by 5
Adipocyte-derived CXCL10 in obesity promotes the migration and invasion of ovarian cancer cells
Wang, Z., Ou, Q., Liu, Y., Liu, Y., Zhu, Q., Feng, J., Han, F., & Gao, L. (2024) · Journal of Ovarian Research · doi:10.1186/s13048-024-01568-0 · Cited by 5
Increasing Rates of Pancreatic and Hepatocellular Cancers Parallel Increasing Obesity Rates
Kumar, S., Moghaddam, S., Goldberg, D. S., Mantero, A. M. A., & Crane, T. E. (2022) · Pancreas · doi:10.1097/mpa.0000000000002153 · Cited by 5
Risk reduction of non-hormonal cancers following bariatric surgery
Jawhar, N., Nakanishi, H., Marrero, K., Tomey, D., Alamy, N. H., Danaf, J., & Ghanem, O. M. (2023) · Minerva Surgery · doi:10.23736/s2724-5691.23.10104-3 · Cited by 5
Han, X., Jemal, A., Zheng, Z., Nogueira, L., Khushalani, J. S., Chen, Z., & Yabroff, K. R. (2021) · Cancer · doi:10.1002/cncr.33842 · Cited by 5
Self-citationTirzepatide inhibits tumor growth in mice with diet-induced obesityPreprint
Huang, L., Zeng, J., Wang, Y., & Pollak, M. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.06.22.546093 · Cited by 5
Sassine, S., Ilinca, A. P., Coltin, H., Bittencourt, H. N. D. S., Athale, U. H., Bowes, L., Brossard, J., Israels, S. J., Johnston, D. L., Kulkarni, K. P., et al. (2025) · Cancer · doi:10.1002/cncr.35673 · Cited by 4
Ihenacho, U., McKinley, M. A., Vu, A., Hernandez, B. Y., Loo, L. W. M., Gomez, S. L., Wu, A. H., & Cheng, I. C. (2022) · Cancer Causes & Control · doi:10.1007/s10552-022-01659-7 · Cited by 4
de Andrade, D. A. P., Guimarães, A. P. G., de Melo, A. C., Nogueira‐Rodrigues, A., Gomes, L. M., Scaranti, M., Maia, J. M. L., Morelle, A. M., Santos, C. L., Souza, C. D. P., et al. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1133277 · Cited by 4
Sánchez-Lastra, M. A., Strain, T., Ding, D., Dalene, K. E., Cruz, B. D. P., Ekelund, U., & Tarp, J. (2024) · Journal of sport and health science/Journal of Sport and Health Science · doi:10.1016/j.jshs.2024.101018 · Cited by 5
Estimation of cancer mortality attributable to excess body weight during 2006–2015 in China
Xu, L., Yang, Z., Li, T., Yu, L., Zhu, Z., Wu, Y., Tang, M., Jin, M., Chen, K., & Wang, J. (2023) · Cancer Epidemiology · doi:10.1016/j.canep.2023.102358 · Cited by 4
Colorectal cancer risk based on extended family history and body mass index
Ochs‐Balcom, H. M., Kanth, P., Farnham, J. M., Abdelrahman, S., & Cannon‐Albright, L. (2020) · Genetic Epidemiology · doi:10.1002/gepi.22338 · Cited by 5
Association of activity-based food environment index with obesity-related cancer mortality in the US
Lin, Q., Chen, X., Xiang, X., Lyu, W., Miao, C., Zhang, G., & Xu, R. (2025) · BMC Medicine · doi:10.1186/s12916-025-03967-6 · Cited by 4
Nanocarrier-enabled delivery of natural antiobesity agents
Chung, Y.-K., Hsu, C., Wang, Y., Tran, T. T. P., Alalaiwe, A. S., & Fang, J. Y. (2025) · Nanomedicine · doi:10.1080/17435889.2025.2534328 · Cited by 5
Jin, X. Y., Wu, M., Dong, S., Liu, H., & Ma, H. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1347724 · Cited by 4
Moore, J. X., Carter, S. J., Williams, V., Khan, S., Lewis‐Thames, M. W., Gilbert, K. L., & Howard, G. (2020) · Preventive Medicine · doi:10.1016/j.ypmed.2020.105989 · Cited by 3
Photon beam energy dependent single-arc volumetric modulated arc optimization
Momin, S., Gräfe, J. L., Georgiou, K., & Khan, R. F. H. (2021) · Physica Medica · doi:10.1016/j.ejmp.2021.02.004 · Cited by 3
Association between Multiple Myeloma and Ulcerative Colitis: A Cross-Sectional Analysis
Bangolo, A., Sagireddy, S., Desrochers, P., Laabidi, I., Nagesh, V. K., Jarri, A. I., Sekhon, I. S., Laabidi, Y., Muralidhar, D., Singh, A., et al. (2023) · Diseases · doi:10.3390/diseases11020059 · Cited by 3
Anstadt, E. J., Carmona, R., Berlin, E. E., Yegya‐Raman, N., Venigalla, S., Reddy, V. K., Williams, G. R., Leibensperger, M. R., Wojcieszynski, A. P., Baumann, B. C., et al. (2023) · Cancer · doi:10.1002/cncr.35058 · Cited by 3
Gorin, S. S., & Hirko, K. A. (2023) · The Cancer Journal · doi:10.1097/ppo.0000000000000686 · Cited by 4
Ray, S., Kapoor, N., Deshpande, N., Chatterjee, S., Kumar, J. S., Tantia, O., Goyal, G., Mukherjee, J. J., & Singh, A. K. (2024) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2024.2330468 · Cited by 3
Okwan-Duodu, D. K., Pandiri, A. R., & Adams, D. J. (2024) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-060424-052905 · Cited by 3
Sun, G., Ma, X., Xu, S., Su, B., Chen, Q., Dong, X., Wang, L., Wan, J., & Shi, H. (2024) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848241307601 · Cited by 3
Tian, Y., Cao, X., Chang, C., Wang, X., Zheng, C., Pei, X., Yu, X. Q., Zhang, Y., Tuerdi, N., Zhao, Z., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102137 · Cited by 3
Zhou, W., Herwald, S. E., Uppot, R. N., & Arellano, R. S. (2020) · Journal of Vascular and Interventional Radiology · doi:10.1016/j.jvir.2020.07.028 · Cited by 3
Association of behavioral risk factors with the development of malignant neoplasms
Каприн, А. Д., Чиссов, В. И., Александрова, Л. М., & Starinsky, V. V. (2021) · Russian Journal of Preventive Medicine · doi:10.17116/profmed202124021109 · Cited by 3
Behavioral Risk Factors: A Guide for Oncology Nurses Counseling Patients
Glenn, D. G. (2020) · Clinical journal of oncology nursing · doi:10.1188/20.cjon.s2.9-18 · Cited by 3
Editorial: Role of Epigenetic Modifications on Diet-Induced Metabolic Diseases
Vinciguerra, M., Masotti, A., & Alisi, A. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00825 · Cited by 3
Impact of the 2025 Lancet Diagnostic Criteria on Obesity Treatment in the United States
Chumakova-Orin, M., Finucane, F. M., Chen, Y., & Juo, Y. (2025) · Clinical Obesity · doi:10.1111/cob.70050 · Cited by 2
Huang, H., Bu, H., Liao, L., Xiang, Y., Chen, Q., Fu, G., Cheng, W., Kou, Y., Liu, Z.-Z., Zheng, K., et al. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2587400 · Cited by 2
Follicle stimulating hormone, luteinizing hormone and adiposity trajectories in postmenopausal women
Yue, Y., Lima, S. M., Hovey, K. M. O., Bea, J. W., Wactawski‐Wende, J., Manson, J. E., Roe, D. J., Funk, J. L., Odegaard, A., Ziller, S. G., et al. (2025) · Climacteric · doi:10.1080/13697137.2025.2595986 · Cited by 2
Sui, D., Liu, F., Zheng, L., Yu, S., Ding, Z., Ren, X., Gao, J., Wang, W., & Yang, L. (2026) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2026.105182 · Cited by 3
A Scoping Review of Influences on HPV Vaccine Uptake in the Rural US
Gorin, S. S., Hyman, R., Olson, C., Fournier, E. A., Yang, K., Hanko, D., & HPV Review Working Group (2026) · Vaccines · doi:10.3390/vaccines14020156 · Cited by 2
OBESITY: THE COVERED RISK OF CANCER
Trifan, A. V. (2023) · The Medical-Surgical Journal · doi:10.22551/msj.2023.01.01 · Cited by 2
Schlechter, C. R., Fiol, G. D., Jones, D. R., Orleans, B., Gibson, B., Nahum-Shani, I. B., Maxfield, E., Locke, A., Cornia, R., Bradshaw, R. L., et al. (2023) · BMJ Open · doi:10.1136/bmjopen-2023-075157 · Cited by 2
Updates in the management of relapsed/refractory multiple myeloma
Hanna, K. S., Larson, S., Nguyen, J. M., Tu, S., Boudreau, J., & Rose, S. (2021) · Journal of Oncology Pharmacy Practice · doi:10.1177/10781552211028906 · Cited by 2
PD-1 is induced on tumor-associated macrophages in obesity to directly restrain anti-tumor immunityPreprint
Bader, J. E., Wolf, M. M., Madden, M. Z., Reinfeld, B. I., Arner, E. N., Hathaway, E. S., Steiner, K. K., Needle, G. A., Landis, M. D., Cottam, M. A., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.11.12.515348 · Cited by 2
Metadata
- Authors
- Islami, F., Goding Sauer, A., Gapstur, S. M., & Jemal, A.
- Affiliations
- American Cancer Society (US)
- Surveillance and Health Services Research, American Cancer Society, Atlanta, Georgia
- Corresponding author
- Islami, Farhad
- Venue
- JAMA Oncology
- Publisher
- American Medical Association (AMA)
- Published
- 2019-03-01
- Volume
- 5
- Issue
- 3
- Pages
- 384
- ISSN
- 2374-2437 (ISSN-L)
- PMC
- PMC6521676
- OpenAlex
- W2906817819
- Cited by
- 153
- References
- 49
- Citations by year
- 2026: 17 · 2025: 20 · 2024: 25 · 2023: 33 · 2022: 24 · 2021: 13 · 2020: 10 · 2019: 10
- FWCI
- 3.09
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- JAMA Oncology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Risks and Factors
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
- Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
- Keywords
- overweight, obesity, cancer incidence, population attributable fraction, body mass index, state-level variation, cancer burden, esophageal adenocarcinoma, multiple myeloma, colorectal cancer, liver cancer, breast cancer, ovarian cancer, cancer prevention, sex differences in cancer risk, United States states
- MeSH terms
- Adult, Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Neoplasms, Nutrition Surveys, Obesity, Risk Factors, Time Factors, United States, Weight Gain, Body Mass Index, Incidence, Prevalence, Age Distribution, Sex Distribution, SEER Program, Risk Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review